aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with dicyclomine in 1 studies
| Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (dicyclomine) | Trials (dicyclomine) | Recent Studies (post-2010) (dicyclomine) |
|---|---|---|---|---|---|
| 253 | 100 | 17 | 398 | 41 | 74 |
| Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | dicyclomine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.468 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.046 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0029 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0024 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0035 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0044 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.625 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.24 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.468 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.21 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.301 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 3.065 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.0049 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mogadam, M | 1 |
1 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and dicyclomine
| Article | Year |
|---|---|
The GI drug column. The ACG committee on FDA related matters.
Topics: Alginates; Aluminum Hydroxide; Antacids; Bicarbonates; Chemical and Drug Induced Liver Injury; Chenodeoxycholic Acid; Cimetidine; Dicyclomine; Drug Combinations; Gastrointestinal Diseases; Humans; Magnesium Hydroxide; Silicic Acid; Simethicone; Sodium Bicarbonate; United States; United States Food and Drug Administration | 1983 |